These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2705449)

  • 21. Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity.
    McCarthy JT; Milliner DS; Johnson WJ
    Q J Med; 1990 Mar; 74(275):257-76. PubMed ID: 2117295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Red blood cell aluminum in patients with renal failure and effect of desferrioxamine infusion.
    Umeda M; Tsurusaki K; Kamikawa S; Izumi N; Yasumoto R; Kishimoto T; Maekawa M
    Blood Purif; 1990; 8(5):295-300. PubMed ID: 2091689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
    Splendiani G; Albano V; Tancredi M; Daniele M; Pignatelli F
    Biomater Artif Cells Artif Organs; 1987; 15(1):175-81. PubMed ID: 3449135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of an erythrocyte aluminum assay in the diagnosis of aluminum-associated microcytic anemia in patients undergoing dialysis and response to deferoxamine therapy.
    Abreo K; Brown ST; Sella M; Trapp G
    J Lab Clin Med; 1989 Jan; 113(1):50-7. PubMed ID: 2909650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodialysis is as effective as hemoperfusion for drug removal in carbamazepine poisoning.
    Tapolyai M; Campbell M; Dailey K; Udvari-Nagy S
    Nephron; 2002 Feb; 90(2):213-5. PubMed ID: 11818708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined high-efficiency hemodialysis and charcoal hemoperfusion in severe N-acetylprocainamide intoxication.
    Kar PM; Kellner K; Ing TS; Leehey DJ
    Am J Kidney Dis; 1992 Oct; 20(4):403-6. PubMed ID: 1384320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Removal of cimetidine by peritoneal dialysis, hemodialysis, and charcoal hemoperfusion.
    Pizzella KM; Moore MC; Schultz RW; Walshe J; Schentag JJ
    Ther Drug Monit; 1980; 2(3):273-81. PubMed ID: 7222181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of desferrioxamine infusion on red blood cell aluminum.
    Umeda M; Umimoto K; Tsurusaki K; Izumi N; Kishimoto T; Maekawa M
    ASAIO Trans; 1988; 34(3):297-9. PubMed ID: 3196524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant iron and aluminum mass transfer following deferoxamine infusion during hemofiltration.
    Canavese C; Salomone M; Pacitti A; Mangiarotti G; Thea A; Dogliani M; Serra A
    Am J Kidney Dis; 1991 Feb; 17(2):179-84. PubMed ID: 1992660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracorporeal treatment of salicylate or acetaminophen poisoning--is there a role?
    Winchester JF; Gelfand MC; Helliwell M; Vale JA; Goulding R; Schreiner GE
    Arch Intern Med; 1981 Feb; 141(3 Spec No):370-4. PubMed ID: 7008736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of combined hemodialysis/hemoperfusion in chronic uremia.
    Stefoni S; Feliciangeli G; Colì L; Prandini R; Bonomini V
    Contrib Nephrol; 1982; 29():123-32. PubMed ID: 6804167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sorbent therapy of the porphyrias. III. Comparative efficacy of experimental plasma perfusion with several commercial hemoperfusion cartridges.
    Tishler PV; Winston SH
    Methods Find Exp Clin Pharmacol; 1984 Jul; 6(7):389-93. PubMed ID: 6503474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coated charcoal hemoperfusion for the removal galactose in rats.
    Nasielski P; Chang TM
    Int J Artif Organs; 1978 May; 1(3):143-7. PubMed ID: 689757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immobilized desferrioxamine (DFO) for the extracorporeal removal of aluminum.
    Anthone S; Ambrus CM; Horvath C; Kalghatgi K
    ASAIO Trans; 1987; 33(3):744-8. PubMed ID: 3676012
    [No Abstract]   [Full Text] [Related]  

  • 35. Hemoperfusion-hemodialysis ineffective for paraquat removal in life-threatening poisoning?
    Van de Vyver FL; Giuliano RA; Paulus GJ; Verpooten GA; Franke JP; De Zeeuw RA; Van Gaal LF; De Broe ME
    J Toxicol Clin Toxicol; 1985; 23(2-3):117-31. PubMed ID: 4057309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?
    Hodsman AB; Hood SA; Brown P; Cordy PE
    J Lab Clin Med; 1985 Dec; 106(6):674-81. PubMed ID: 4067379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desferrioxamine in the treatment of aluminum overload.
    Ackrill P; Day JP
    Clin Nephrol; 1985; 24 Suppl 1():S94-7. PubMed ID: 3842106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential and simultaneous "in series" hemodialysis and hemoperfusion in the management of theophylline intoxication.
    Hootkins R; Lerman MJ; Thompson JR
    J Am Soc Nephrol; 1990 Dec; 1(6):923-6. PubMed ID: 2103852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of aluminoxamine and feroxamine chelates in dialysis patients.
    Canavese C; Gurioli L; D'Amicone M; Cardelli R; Caligaris F; Bongiorno P; Arnaud A; Mattiello G; Marchiori M
    Nephron; 1992; 60(4):411-7. PubMed ID: 1584315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sorbent therapy of the porphyrias. II. Experimental plasma or hemoperfusion with a commercial charcoal cartridge.
    Tishler PV; Gordon BJ
    Methods Find Exp Clin Pharmacol; 1983; 5(3):185-91. PubMed ID: 6888085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.